---
title: "Transitional Drugs 3"
ocid: "ocds-h6vhtk-04c9a9"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04c9a9"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04c9a9.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04c9a9.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP - PROCUREMENT SERVICES (ON BEHALF OF ALL WALES UHBS & TRUSTS"
published: "2025-05-14"
---

# Transitional Drugs 3

Buyer: VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP - PROCUREMENT SERVICES (ON BEHALF OF ALL WALES UHBS & TRUSTS  
Current stage: Award  
OCID: ocds-h6vhtk-04c9a9

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04c9a9)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04c9a9.json)

## Summary

The public procurement process titled "Transitional Drugs 3" was handled by Velindre NHS Trust, acting on behalf of NHS Wales Shared Services Partnership, covering all Wales UHBs & Trusts. This procurement falls under the pharmaceutical products industry category and aims to acquire drugs that have recently lost their patent exclusivity. Buyers and suppliers are operating within the UK, and the main location of delivery is in the UKL region. The procurement was conducted through an open procedure, reflecting its commitment to transparency and competition. The tender process began with an announcement on 19th December 2024 and submissions closed on 23rd January 2025. The award phase commenced immediately after, with contracts being signed by 15th April 2025. This tender was successfully awarded to multiple suppliers, with the process currently in the award stage and all contracts deemed active.

This procurement process offers valuable opportunities for businesses in the pharmaceutical industry, particularly those capable of supplying high-quality goods at competitive prices. With a focus on quality, cost, and social value, the tender was an ideal fit for established pharmaceutical companies. The awarded contracts, each carrying significant financial value, are likely to provide robust growth avenues for suppliers like Celltrion Healthcare UK Ltd and Amgen Ltd, among others, potentially expanding their footprint within the UK healthcare market. Businesses with capabilities in drug manufacturing and distribution, particularly those with expertise in pharmaceuticals losing patent exclusivity, would find this tender suitable for scaling operations and increasing market share within the healthcare procurement sector. The framework also offers an extension option, further enhancing long-term business prospects.

## Notice

Drugs which have recently lost their patent exclusivity

### Lot Information

Lot 1

Transitional Drugs 3

Renewal: This framework includes the option to extend for up to a further 24 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/021504-2025 |
| Notice type | Tender Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 14 May 2025 |
| Submission deadline | 23 Jan 2025 |
| Future notice date | Not specified |
| Award date | 14 Apr 2025 |
| Contract period | 31 Mar 2025 - 30 Jun 2026 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £15,169,777 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £29,045,630 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP - PROCUREMENT SERVICES (ON BEHALF OF ALL WALES UHBS & TRUSTS |
| Additional buyers | VELINDRE NHS TRUST |
| Locality | NEWPORT |
| Post town | Newport |
| Postcode | NP10 8BE |
| Country | Wales |
| ITL 1 | TLL Wales |
| ITL 2 | TLL5 South East Wales |
| ITL 3 | TLL54 Monmouthshire and Newport |
| Local authority | Newport |
| Electoral ward | Tredegar Park and Marshfield |
| Westminster constituency | Newport West and Islwyn |
| Delivery location | TLL Wales |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 11 |
| Supplier names | AMGEN; BIOGEN IDEC; CELIX PHARMA; CELLTRION HEALTHCARE; FRESENIUS KABI; ROCHE PRODUCTS; SANDOZ; SUN PHARMA; THORNTON & ROSS; TILLOMED LABORATORIES; ZENTIVA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 14 May 2025 at 18:27 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/021504-2025
- 19 Dec 2024 at 14:50 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/041002-2024

## Notice URLs

- http://www.etenderwales.bravosolution.co.uk/nhs/
- http://www.procurement.wales.nhs.uk
- https://etenderwales.bravosolution.co.uk/nhs
- https://etenderwales.bravosolution.co.uk/nhs/
- https://nwssp.nhs.wales/ourservices/procurement-services/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04c9a9. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04c9a9.json.